Tag:
iclaprim
Latest Headlines
Latest Headlines
Arpida shares continue fall as analysts raise doubts
Investors continued to beat a hasty retreat from Arpida's stock after analysts raised doubts about any quick approval of its new antibiotic iclaprim and cautioned that the company would likely need
Rising Arpida shares suspended ahead of FDA review
An FDA advisory committee is reviewing three new antibiotics this week, and investors are working overtime trying to figure out who will win or lose. Trading in shares of Switzerland's Arpida had to
